TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Christopher B. Rodell(Drexel University), Ralph Weissleder(Massachusetts General Hospital), Rainer H. Köhler(Massachusetts General Hospital), Sean P. Arlauckas(Massachusetts General Hospital), Michael F. Cuccarese(Center for Systems Biology), Christopher Garris(Massachusetts General Hospital), Mikaël J. Pittet(University of Geneva), Ran Li(Massachusetts General Hospital), Maaz S. Ahmed(Massachusetts General Hospital)
Nature Biomedical Engineering
May 18, 2018
Cited by 1,070


Related Papers